Obesity and menstrual disorders

被引:63
作者
Seif, Mourad W. [1 ,2 ]
Diamond, Kathryn [1 ]
Nickkho-Amiry, Mahshid [1 ,2 ]
机构
[1] St Marys Hosp, CMFT, Manchester M13 0JH, Lancs, England
[2] Univ Manchester, Manchester, Lancs, England
关键词
menstrual disorders; obesity; hormones; heavy menstrual bleeding; surgery; POLYCYSTIC-OVARY-SYNDROME; BODY-MASS INDEX; ENDOMETRIAL ABLATION; DEPOT MEDROXYPROGESTERONE; BARIATRIC SURGERY; WEIGHT; WOMEN; ASSOCIATION; GONADOTROPIN; CANCER;
D O I
10.1016/j.bpobgyn.2014.10.010
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Obese women often present with oligomenorrhoea, amenorrhoea or irregular periods. The association between obesity and heavy menstrual bleeding is not well documented and data on its prevalence are limited. While the investigation protocols should be the same as for women of normal weight, particular focus is required to rule out endometrial hyperplasia in obese women. The treatment modalities of menstrual disorders for obese women will be, in principle, similar to those of normal weight. However, therapeutic outcomes in terms of effectiveness and adverse outcomes need special consideration when dealing with women with a high body mass index (BMI). Here, different treatment strategies are reviewed paying particular attention to the effect of weight on their efficacy and the challenges of providing each treatment option. This chapter aims to review the current literature and address areas where further evidence is needed, which will subsequently influence clinical practice. (C) 2014 Published by Elsevier Ltd.
引用
收藏
页码:516 / 527
页数:12
相关论文
共 64 条
[1]   The surgical management of menorrhagia [J].
Abbott, JA ;
Garry, R .
HUMAN REPRODUCTION UPDATE, 2002, 8 (01) :68-78
[2]   LEVONORGESTREL-RELEASING INTRAUTERINE-DEVICE IN THE TREATMENT OF MENORRHAGIA [J].
ANDERSSON, JK ;
RYBO, G .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1990, 97 (08) :690-694
[3]  
[Anonymous], 2003, Drug Ther Bull, V41, P41
[4]  
[Anonymous], COCHRANE DATABASE SY
[5]  
AZZIZ R, 1989, FERTIL STERIL, V52, P703
[6]   Weight gain in obese and nonobese adolescent girls initiating depot medroxyprogesterone, oral contraceptive pills, or no hormonal contraceptive method [J].
Bonny, AE ;
Ziegler, J ;
Harvey, R ;
Debanne, SM ;
Secic, M ;
Cromer, BA .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2006, 160 (01) :40-45
[7]  
Bray George A., 1997, Human Reproduction (Oxford), V12, P26
[8]   Ultrasound and menstrual history in predicting endometrial hyperplasia in polycystic ovary syndrome [J].
Cheung, AP .
OBSTETRICS AND GYNECOLOGY, 2001, 98 (02) :325-331
[9]   Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review [J].
Chittenden, B. G. ;
Fullerton, G. ;
Maheshwari, A. ;
Bhattacharya, S. .
REPRODUCTIVE BIOMEDICINE ONLINE, 2009, 19 (03) :398-405
[10]   Serum immunoreactive leptin concentrations in normal-weight and obese humans [J].
Considine, RV ;
Sinha, MK ;
Heiman, ML ;
Kriauciunas, A ;
Stephens, TW ;
Nyce, MR ;
Ohannesian, JP ;
Marco, CC ;
McKee, LJ ;
Bauer, TL ;
Caro, JF .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :292-295